AIM ImmunoTech has implemented a Cash Conservation Plan to support the company's clinical milestones and shareholder value. The plan aims to maintain momentum in critical medical areas and enhance shareholder returns through Ampligen's potential in addressing unmet needs.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing